| 808 | 1 | 149 |
| 下载次数 | 被引频次 | 阅读次数 |
信号转导和转录活化因子1(Signal transducer and activator of transcription 1,STAT1)是干扰素信号通路中的关键分子，在对抗病毒和其他病原体的免疫反应中发挥重要作用，构建STAT1敲除细胞系有助于研究其在病毒感染过程中的作用与机制。本研究利用CRISPR/Cas9(Clustered regularly interspaced short palindromic repeats-Cas9)基因编辑技术构建STAT1基因敲除细胞系。首先构建STAT1基因特异性打靶载体，后通过慢病毒转导人非小细胞肺癌细胞系（Human non-small cell lung cancer cells,A549），嘌呤霉素筛选稳定转导的细胞后进行单克隆化，最后对获取的单克隆细胞在分子水平上进行敲除及敲除回补验证，成功构建一株STAT1基因敲除（STAT1 gene knockout,STAT1-KO）的A549细胞，且该细胞系可维持正常细胞活性与增殖能力。以汉滩病毒（Hantaan virus,HTNV）感染验证，发现在该细胞系中病毒复制水平明显升高。本研究成功构建了一株STAT1-KO A549细胞，可为抗病毒药物和干扰素信号通路研究提供有力工具。
Abstract：Signal transducer and activator of transcription(STAT)-1 is a key molecule in the interferon signaling pathway. It plays an important part in the immune response against viruses and other pathogens.Therefore, construction of a STAT1 knockout cell line(STAT1-KO) can aid study of its role in viral infection.STAT1-KO was constructed using clustered regularly interspaced short palindromic repeats(CRISPR)/CRISPR-associated protein 9(Cas9) gene-editing technology. First, a STAT1-specific targeting vector was constructed, and human non-small-cell lung cancer(A549) cells were transduced by lentivirus. Stable transduced cells were screened by puromycin and monoclonal antibodies. Finally, the obtained monoclonal cells were verified at the molecular level, and a STAT1-KO A549 cell line was constructed. This cell line could maintain normal cell activity and proliferation ability. Validation was undertaken with infection by the Hantaan virus. The level of viral replication was increased significantly in this cell line. In conclusion, we constructed a STAT1-KO A549 cell line, which could be a powerful tool for the study of antiviral drugs and interferon signaling pathway.
[1] Majoros A, Platanitis E, Kernbauer-H?lzl E, et al.Canonical and non-canonical aspects of JAK–STAT signaling:Lessons from interferons for cytokine responses[J]. Front Immunol, 2017, 8:29. DOI:10. 3389/fimmu. 2017. 00029.
[2] Lim C P, Cao X. Structure, function, and regulation of STAT proteins[J]. Mol BioSyst, 2006, 2(11):536.DOI:10. 1039/b606246f.
[3] Tolomeo M, Cascio A. The multifaced role of STAT3in cancer and its implication for anticancer therapy[J].Int J Mol Sci, 2021, 22(2):603. DOI:10. 3390/ijms22020603.
[4] Tolomeo M, Meli M, Grimaudo S. STAT5 and STAT5 inhibitors in Hematological Malignancies[J].Anticancer Agents Med Chem, 2020, 19(17):2036–2046. DOI:10. 2174/1871520619666190906160848.
[5] Dale T C, Imam A M, Kerr I M, et al. Rapid activation by interferon alpha of a latent DNA-binding protein present in the cytoplasm of untreated cells.[J].PNAS, 1989, 86(4):1203–1207. DOI:10. 1073/pnas. 86. 4. 1203.
[6] Levy D E, Kessler D S, Pine R, et al. Cytoplasmic activation of ISGF3, the positive regulator of interferonalpha-stimulated transcription, reconstituted in vitro.[J]. Gene Dev, 1989, 3(9):1362–1371. DOI:10. 1101/gad. 3. 9. 1362.
[7] Ihle J N. The janus kinase family and signaling through members of the cytokine receptor superfamily[J]. Exp Biol Med, 1994, 206(3):268–272. DOI:10. 3181/00379727-206-43757.
[8] Wang X, Lupardus P, LaPorte S L, et al. Structural Biology of Shared Cytokine Receptors[J]. Annu Rev Immunol, 2009, 27(1):29–60. DOI:10. 1146/annurev. immunol. 24. 021605. 090616.
[9] Seidel H M, Milocco L H, Lamb P, et al. Spacing of palindromic half sites as a determinant of selective STAT(signal transducers and activators of transcription)DNA binding and transcriptional activity.[J]. PNAS, 1995, 92(7):3041–3045. DOI:10. 1073/pnas. 92. 7. 3041.
[10]Gao S, Von der Malsburg A, Paeschke S, et al.Structural basis of oligomerization in the stalk region of dynamin-like MxA[J]. Nature, 2010, 465(7297):502–506. DOI:10. 1038/nature08972.
[11]Brass A L, Huang I-C, Benita Y, et al. The IFITM Proteins Mediate Cellular Resistance to Influenza A H1N1 Virus, West Nile Virus, and Dengue Virus[J].Cell, 2009, 139(7):1243–1254. DOI:10. 1016/j.cell. 2009. 12. 017.
[12]Diamond M S, Farzan M. The broad-spectrum antiviral functions of IFIT and IFITM proteins[J]. Nat Rev Immumol, 2012, 13(1):46–57. DOI:10. 1038/nri3344.
[13]Ran F A, Hsu P D, Wright J, et al. Genome engineering using the CRISPR-Cas9 system[J]. Nat Protoc, 2013, 8(11):2281–2308. DOI:10. 1038/nprot. 2013. 143.
[14]Majoros A, Platanitis E, Kernbauer-H?lzl E, et al.Canonical and Non-Canonical Aspects of JAK–STAT Signaling:Lessons from Interferons for Cytokine Responses[J]. Front Immunol, 2017, 8(74):29.DOI:10. 3389/fimmu. 2017. 00029.
[15]Lee, H W, and H J Cho.“Electron microscope appearance of Hantaan virus, the causative agent of Korean haemorrhagic fever.[J]. The Lancet, 1981, 317(8229):1070–1072. DOI:10. 1016/s0140-6736(81)92240-6.
[16]Lieber M, Todaro G, Smith B, et al. A continuous tumor-cell line from a human lung carcinoma with properties of type II alveolar epithelial cells[J]. Int. J.Cancer, 1976, 17(1):62–70. DOI:10. 1002/ijc. 2910170110.
[17]Okamoto H. Efficient cell culture systems for hepatitis E virus strains in feces and circulating blood[J]. Rev Med Virol, 2011, 21(1):18–31. DOI:10. 1002/rmv. 678.
[18]唐万达，赵平，任瑞文，等.人肺腺癌细胞A549对蜱媒脑炎病毒的易感性分析[J].海军军医大学学报，2022, 43(05):478–483. DOI:10. 16781/j. cn31-2187/r. 20210518.
[19]马雪萍，姚华，王雪，等.滨蒿总黄酮对H1N1流感病毒感染的A549细胞先天免疫信号通路的影响[J].世界科学技术-中医药现代化，2021, 23(12):4724–4734.
[20]Ran F A, Hsu P D, Lin C-Y, et al. Double Nicking by RNA-Guided CRISPR Cas9 for Enhanced Genome Editing Specificity[J]. Cell, 2013, 154(6):1380–1389. DOI:10. 1016/j. cell. 2013. 08. 021.
[21]Wu Y, Ma L, Zhuang Z, et al. Main protease of SARSCoV-2 serves as a bifunctional molecule in restricting type I interferon antiviral signaling[J]. Signal Transduct Tar, 2020, 5(1):221. DOI:10. 1038/s41392-020-00332-2.
[22]Wang Chingying, Huang Ancheng, Hour M-J, et al.Antiviral Potential of a Novel Compound CW-33 against Enterovirus A71 via Inhibition of Viral 2A Protease[J].Viruses, 2015, 7(6):3155–3171. DOI:10. 3390/v7062764.
[23]Devaux P, Von Messling V, Songsungthong W, et al.Tyrosine 110 in the measles virus phosphoprotein is required to block STAT1 phosphorylation[J].Virology, 2007, 360(1):72–83. DOI:10. 1016/j.virol. 2006. 09. 049.
[24]Mateo M, Reid St P, Leung L W, et al. Ebolavirus VP24 Binding to Karyopherins Is Required for Inhibition of Interferon Signaling[J]. J. virol, 2010, 84(2):1169–1175. DOI:10. 1128/jvi. 01372-09.
[25]G?ertz G P, McNally K L, Robertson S J, et al. The Methyltransferase-Like Domain of Chikungunya Virus nsP2 Inhibits the Interferon Response by Promoting the Nuclear Export of STAT1[J] J. virol, 2018, 92(17):10–1128. DOI:10. 1128/jvi. 01008-18.
[26]Christen V, Duong F, Bernsmeier C, et al. Inhibition of Alpha Interferon Signaling by Hepatitis B Virus[J]. J Virol, 2007, 81(1):159–165. DOI:10. 1128/jvi. 01292-06.
[27]Zhang S, Huo C, Xiao J, et al. P-STAT1 regulates the influenza A virus replication and inflammatory response in vitro and vivo[J]. Virology, 2019, 537:110–120.DOI:10. 1016/j. virol. 2019. 08. 023.
[28]Cervasi B, Paiardini M, Serafini S, et al.Administration of Fludarabine-Loaded Autologous Red Blood Cells in Simian Immunodeficiency Virus-Infected Sooty Mangabeys Depletes pSTAT-1-Expressing Macrophages and Delays the Rebound of Viremia after Suspension of Antiretroviral Therapy[J]. J. virol,2006, 80(21):10335–10345. DOI:10. 1128/jvi. 00472-06.
[29]Suzuki K, Tsunekawa Y, Hernandez-Benitez R, et al.In vivo genome editing via CRISPR/Cas9 mediated homology-independent targeted integration[J]. Nature,2016, 540(7631):144–149. DOI:10. 1038/nature20565.
[30]刘铁柱，黄涛，李阿茜.基于慢病毒包装和CRISPR技术建立病毒感染关键基因CLTC敲除细胞系[J].病毒学报，2023, 39(03):800–804. DOI:10. 13242/j.cnki. bingduxuebao. 004336.
[31]Si Y, Zhang H, Zhou Z, et al. RIPK3 promotes hantaviral replication by restricting JAK-STAT signaling without triggering necroptosis[J]. Virol,2023, 38(5):741–754. DOI:10. 1016/j.virs. 2023. 08. 006.
[32]Levine J R, Prescott J, Brown K S, et al. Antagonism of Type I Interferon Responses by New World Hantaviruses[J]. J Virol, 2010, 84(22):11790–11801. DOI:10. 1128/jvi. 00916-10.
基本信息:
DOI：10.13242/j.cnki.bingduxuebao.004512
中图分类号:R373
引用信息:
[1]张俊梅,王芳,应旗康等.利用CRISPR/Cas9技术建立STAT1敲除细胞系及其功能验证[J].病毒学报,2024,40(03):519-527.DOI:10.13242/j.cnki.bingduxuebao.004512.
基金信息:
国家自然科学基金面上项目（项目号：81971563）,题目：基于汉滩和汉城病毒包膜糖蛋白保守区域设计的肾综合征出血热通用亚单位疫苗的研究;国家自然科学基金面上项目（项目号：82272330）,题目：NLRC3-mTORC1轴介导的T细胞代谢重编程在HFRS急性肾损伤中的作用与机制研究; 青年科学基金（项目号：82302525）,题目：GSK3β通过磷酸化降解NP抑制汉滩病毒感染的作用和机制研究~~